Fatima Mraiche Selected Research

empagliflozin

6/2022

Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatima Mraiche Research Topics

Disease

10	Neoplasms (Cancer) 03/2022 - 01/2016
8	Cardiomegaly (Heart Hypertrophy) 06/2022 - 08/2010
7	Hypertrophy 06/2022 - 06/2011
5	Ischemia 09/2012 - 05/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2011
3	Fibrosis (Cirrhosis) 12/2019 - 06/2015
2	Adenocarcinoma of Lung 11/2020 - 07/2016
2	Infections 11/2018 - 08/2007
2	Reperfusion Injury 09/2012 - 12/2011
2	Heart Diseases (Heart Disease) 09/2012 - 12/2011
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	COVID-19 03/2022
1	Hemorrhage 01/2022
1	Insulin Resistance 11/2021
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Hyperglycemia 11/2021
1	Breast Neoplasms (Breast Cancer) 04/2021
1	Neoplasm Metastasis (Metastasis) 04/2021
1	Myocardial Infarction 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Heart Failure 01/2020
1	Pathologic Processes 12/2019
1	Edema (Dropsy) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Hearing Loss (Hearing Impairment) 11/2018
1	Cardiotoxicity 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Cardiomyopathies (Cardiomyopathy) 08/2010
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2007

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2007
10	Protein Isoforms (Isoforms)IBA 06/2022 - 12/2008
7	Sodium-Hydrogen ExchangersIBA 06/2015 - 05/2007
5	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 11/2020 - 01/2015
5	OsteopontinIBA 12/2019 - 01/2015
4	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 11/2021
2	BI D1870IBA 11/2020 - 07/2016
2	AntioxidantsIBA 01/2019 - 01/2017
2	sanguinarineIBA 01/2019 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2016 - 01/2016
2	Mitogen-Activated Protein KinasesIBA 01/2016 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2015 - 01/2015
1	empagliflozinIBA 06/2022
1	Angiotensin IIIBA 06/2022
1	SymportersIBA 03/2022
1	dapagliflozinIBA 03/2022
1	SodiumIBA 03/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	gelatin methacryloylIBA 04/2021
1	HydrogelsIBA 04/2021
1	GoldIBA 12/2020
1	Cathepsin BIBA 12/2020
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020
1	Cytochrome P-450 CYP2C9IBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	AnticoagulantsIBA 01/2019
1	PhytochemicalsIBA 01/2019
1	CarrageenanIBA 01/2019
1	GlycosaminoglycansIBA 09/2018
1	Cell Surface ReceptorsIBA 09/2018
1	Hyaluronic Acid (Hyaluronan)IBA 09/2018
1	Hormones (Hormone)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	CurcuminIBA 01/2018
1	XenobioticsIBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Heavy MetalsIBA 01/2018
1	UbiquitinIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Biological ProductsIBA 01/2017
1	AlkaloidsIBA 01/2017
1	Glycogen Synthase (Synthase I)IBA 07/2016
1	RadonIBA 01/2016
1	AsbestosIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Environmental CarcinogensIBA 01/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2015
1	Calcineurin InhibitorsIBA 06/2015
1	N- (2- methyl- 4,5- bis(methylsulfonyl)benzoyl)guanidineIBA 06/2015
1	Atrial Natriuretic Factor (ANF)IBA 01/2015
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 06/2011
1	CalciumIBA 12/2008
1	Adenosine Triphosphate (ATP)IBA 05/2007

Therapy/Procedure

1	Percutaneous Coronary Intervention 01/2022
1	Stents 01/2022
1	Therapeutics 11/2018